FY23 Corporate Strategy and Sustainability Journey
Core businesses - Our PSAI
business is...
A Essential for our
competitive advantage
B
Key to leveraging our
current portfolio across
markets
Key to enable global
access to address unmet
patient needs
1
API
2
Develop, manufacture and sell APIs to customers globally
Aim to backward-integrate 70%+ core molecules in next 5 years
225+ active DMFs, 55+ products in pipeline
API+
Institutional & B2B sales of value-added offerings above the API
Currently in 25+ countries; Aim to be in 60+ countries in next 5 years
3 Discovery + CDMO (APSL)
Discovery + CDMO services to originator & biotech companies
Serving 3 of top 5 innovators and 120 biotech companies globally
Health access business
Working with public health institutions to enhance access
5Mn+ lives during Covid-19; Aim to impact 500Mn+ lives in the next
five years
19
© copyright Dr. Reddy's Ltd.View entire presentation